Shuttle Pharmaceuticals Holdings (SHPH) Other Operating Expenses (2021 - 2026)
Shuttle Pharmaceuticals Holdings (SHPH) posted quarterly Other Operating Expenses of $789026.0 for Q1 2026, up 1.1% year-over-year from $780427.0 in Q1 2025, and down 28.38% quarter-over-quarter from $1.1 million in Q4 2025.
Shuttle Pharmaceuticals Holdings (SHPH) Other Operating Expenses (2021 - 2026) Analysis & Trends
Shuttle Pharmaceuticals Holdings' Other Operating Expenses history runs 6 years deep, the most recent figure standing at $789026.0 for Q1 2026.
- In Q1 2026, Other Operating Expenses rose 1.1% year-over-year to $789026.0; the TTM figure through Mar 2026 stood at $2.9 million (down 3.14% YoY), while the FY2025 annual figure was $2.2 million, down 18.46% from the prior year.
- Other Operating Expenses for Q1 2026 stood at $789026.0, down from $1.1 million in the prior quarter.
- The five-year high for Other Operating Expenses was $1.3 million in Q3 2024, with the low at $162769.0 in Q4 2022.
- The 5-year median for Other Operating Expenses is $416688.0 (2023), against an average of $517705.4.
- Peak annual rise in Other Operating Expenses reached 574.42% in 2022, while the deepest fall reached 69.28% in 2022.
- Shuttle Pharmaceuticals Holdings' Other Operating Expenses stood at $162769.0 in 2022, then soared by 67.6% to $272800.0 in 2023, then increased by 20.7% to $329265.0 in 2024, then soared by 234.58% to $1.1 million in 2025, then decreased by 28.38% to $789026.0 in 2026.
- Business Quant data shows SHPH's Other Operating Expenses at $789026.0 in Q1 2026, $1.1 million in Q4 2025, and $480887.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Shuttle Pharmaceuticals Holdings | 1.93 Mn | 1.93 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 789,026.00 |
| Dec 31, 2025 | 1.10 Mn |
| Sep 30, 2025 | 480,887.00 |
| Jun 30, 2025 | 538,536.00 |
| Mar 31, 2025 | 780,427.00 |
| Dec 31, 2024 | 329,265.00 |
| Sep 30, 2024 | 1.32 Mn |
| Jun 30, 2024 | 572,596.00 |
| Mar 31, 2024 | 460,238.00 |
| Dec 31, 2023 | 272,800.00 |
| Sep 30, 2023 | 288,416.00 |
| Jun 30, 2023 | 416,688.00 |
| Mar 31, 2023 | 367,624.00 |
| Dec 31, 2022 | 162,769.00 |
| Sep 30, 2022 | 328,687.00 |
| Jun 30, 2022 | 260,680.00 |
| Mar 31, 2022 | 328,712.00 |
| Dec 31, 2021 | 529,798.00 |
| Sep 30, 2021 | 48,736.00 |